Cite
Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.
MLA
Tozaki M, et al. “Monitoring of Early Response to Neoadjuvant Chemotherapy in Breast Cancer with (1)H MR Spectroscopy: Comparison to Sequential 2-[18F]-Fluorodeoxyglucose Positron Emission Tomography.” Journal of Magnetic Resonance Imaging, vol. 28, no. 2, Aug. 2008, pp. 420–27. EBSCOhost, https://doi.org/10.1002/jmri.21454.
APA
Tozaki M, Sakamoto M, Oyama Y, O’uchi T, Kawano N, Suzuki T, Yamashiro N, Ozaki S, Sakamoto N, Higa K, Abe S, Ogawa T, & Fukuma E. (2008). Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography. Journal of Magnetic Resonance Imaging, 28(2), 420–427. https://doi.org/10.1002/jmri.21454
Chicago
Tozaki M, Sakamoto M, Oyama Y, O’uchi T, Kawano N, Suzuki T, Yamashiro N, et al. 2008. “Monitoring of Early Response to Neoadjuvant Chemotherapy in Breast Cancer with (1)H MR Spectroscopy: Comparison to Sequential 2-[18F]-Fluorodeoxyglucose Positron Emission Tomography.” Journal of Magnetic Resonance Imaging 28 (2): 420–27. doi:10.1002/jmri.21454.